Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Credit agrmnt [a]

IMPEL PHARMACEUTICALS INC (IMPL) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/12/2023 4 Kalb Michael Wayne (CFO) has filed a Form 4 on IMPEL PHARMACEUTICALS INC
Txns: Granted 175,000 options to buy @ $2.43, valued at $425.3k
Granted 47,500 options to buy @ $0
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 SHAH MAHENDRA (Director) has filed a Form 4 on IMPEL PHARMACEUTICALS INC
Txns: Granted 12,789 options to buy @ $8.65, valued at $110.6k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/30/2022 4 SHREWSBURY STEPHEN B (Chief Medical Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Exercised 24,606 options to buy @ $1.97, valued at $48.5k
01/28/2022 4 SHREWSBURY STEPHEN B (Chief Medical Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Granted 30,000 options to buy @ $9.85, valued at $295.5k
01/28/2022 4 Paolillo Leonard (Chief Commercial Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Granted 40,000 options to buy @ $9.85, valued at $394k
01/28/2022 4 Leaman John Harold (Chief Fin. & Business Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Granted 100,000 options to buy @ $9.85, valued at $985k
01/28/2022 4 Hoekman John (Chief Scientific Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Granted 35,000 options to buy @ $9.85, valued at $344.8k
01/28/2022 4 ADAMS ADRIAN (COB, CEO and President) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Granted 175,000 options to buy @ $9.85, valued at $1.7M
12/23/2021 4 Hoekman John (Chief Scientific Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Exercised 20,000 options to buy @ $1.64, valued at $32.8k
11/22/2021 4 NELSON TIMOTHY S (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Bought 10,000 shares @ $10.7554, valued at $107.6k
10/21/2021 4 Leaman John Harold (Chief Fin. & Business Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Granted 10,571 options to buy @ $0
09/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/13/2021 4 Wilfong Diane E. (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Granted 11,500 options to buy @ $9.96, valued at $114.5k
07/13/2021 4 SHAH MAHENDRA (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Granted 11,500 options to buy @ $9.96, valued at $114.5k
07/13/2021 4 PARKER H STEWART (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Granted 11,500 options to buy @ $9.96, valued at $114.5k
07/13/2021 4 NELSON TIMOTHY S (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Granted 11,500 options to buy @ $9.96, valued at $114.5k
07/13/2021 4 Allison David D. (Director) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Granted 11,500 options to buy @ $9.96, valued at $114.5k
04/29/2021 4 Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Converted 710,190 shares @ $0
Converted 98,068 shares @ $0
Converted 474,713 shares @ $0
Converted 65,552 shares @ $0
Converted 440,119 shares @ $0
Converted 60,813 shares @ $0
Converted 315,328 shares @ $0
Converted 43,550 shares @ $0
Converted 89,145 shares @ $13.5, valued at $1.2M
Converted 12,311 shares @ $13.5, valued at $166.2k
Bought 505,620 shares @ $15, valued at $7.6M
04/29/2021 4 5AM Ventures V, L.P. (10% Owner) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Converted 808,259 shares @ $0
Converted 540,265 shares @ $0
Converted 500,932 shares @ $0
Converted 358,878 shares @ $0
Converted 101,457 shares @ $13.5, valued at $1.4M
Bought 575,000 shares @ $15, valued at $8.6M
Converted 13,233,885 preferred shares @ $0
Converted 8,845,942 preferred shares @ $0
Converted 8,201,930 options to buy @ $0
Converted 5,876,034 preferred shares @ $0
Converted 1,359,799 convertible notes @ $13.5, valued at $18.4M
04/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2021 4 Hoekman John (Chief Scientific Officer) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Converted 4,523 shares @ $0
Disposed of 275 shares @ $0
Exercised (in-or-at-the-money) 8,523 options to buy @ $8.19, valued at $69.8k
Exercised (in-or-at-the-money) 8,523 preferred shares @ $0
Converted 69,657 preferred shares @ $0
04/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/26/2021 4 Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on IMPEL NEUROPHARMA INC
Txns: Acquired convertible notes @ $0
Acquired convertible notes @ $0
04/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy